Cure predictability during parathyroidectomy

World Journal of Surgery

Volumn 38, Issue 3, 2014, Pages 525-533

  Udelsman, Robert ^a   Donovan, Patricia ^a   Shaw, Cary ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Cary S Shaw and Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PARATHYROID HORMONE;

ARTICLE; BLOOD; DECISION SUPPORT SYSTEM; EVALUATION STUDY; HUMAN; MULTIVARIATE ANALYSIS; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; STATISTICAL MODEL; TREATMENT OUTCOME;

BIOLOGICAL MARKERS; DECISION SUPPORT TECHNIQUES; HUMANS; HYPERPARATHYROIDISM, PRIMARY; LOGISTIC MODELS; MULTIVARIATE ANALYSIS; PARATHYROID HORMONE; PARATHYROIDECTOMY; TREATMENT OUTCOME;

EID: 84894645067     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-013-2327-8     Document Type: Review

References (16)

1. Golden SH, Robinson KA, Saldanha I et al (2009) Clinical review: prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review. J Clin Endocrinol Metab 94:1853-1878
2. Bilezikian JP, Khan AA, Potts JT Jr (2009) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Third International Workshop. J Clin Endocrinol Metab 94(2):335-339
3. Silverberg SJ, Lewiecki EM, Mosekilde L et al (2009) Presentation of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop. J Clin Endocrinol Metab 94(2):351-365
4. Kunstman JW, Kirsch JD, Mahajan A et al (2013) Parathyroid localization and implications for clinical management. J Clin Endocrinol Metab 98(3):902-912
5. Starker LF, Fonseca AL, Carling T et al (2011) Minimally invasive parathyroidectomy. Int J Endocrinol 2011:1-8
6. Sokoll LJ, Donovan P, Udelsman R (2007) The NACB laboratory medicine practice guidelines for intraoperative PTH. Point Care 6:253-260
7. Udelsman R, Lin Z, Donovan P (2011) The superiority of minimally invasive parathryoidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg 253(3):585-591
8. Carneiro-Pla D (2011) Contemporary and practical uses of intraoperative parathyroid hormone monitoring. Endocr Pract 17(1):44-53
9. Sokoll LJ, Drew H, Udelsman R (2000) Intraoperative parathyroid hormone analysis: a study of 200 consecutive cases. Clin Chem 46(10):1662-1668
10. Libutti SK, Alexander HR, Bartlett DL et al (1999) Kinetic analysis of the rapid intraoperative parathyroid hormone assay in patients during operation for hyperparathyroidism. Surgery 126:1145-1151
11. Riss P, Kaczirek K, Bieglmayer C, Niederle B (2007) PTH spikes during parathyroid exploration - a possible pitfall during PTH monitoring? Langenbecks Arch Surg 392:427-430
12. Richards MS, Thompson GB, Farley DR, Grant CS (2011) An optimal algorithm for intraoperative parathyroid hormone monitoring. Arch Surg 146(3):280-285
13. Singh DN, Gupta SK, Chand G et al (2012) Intra-operative parathyroid hormone kinetics and influencing factors with high baseline PTH: a prospective study. Clin Endocrinol 78:935-941
14. Mazeh H, Chen H, Leverson G, Sippel RS (2013) Creation of a "Wisconsin Index" nomogram to predict the likelihood of additional hypersecreting parathyroid glands during parathyroidectomy. Ann Surg 257:138-141
15. Davis DD, Tec MC, Kowal J et al (2013) Streamlining of intra-operative parathyroid hormone measurements for cure during parathyroidectomy. Am J Surg 205:597-601
16. Carneiro DM, Solozano CC, Nader MC et al (2003) Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery 134(6):973-979